Silverio A, Di Maio M, Prota C, et al
Because it's not just a lower A1C
Each provides a different piece of the puzzle, and together they paint a picture that is concerning enough to warrant attention but not alarming enough to discourage GLP-1 medication use entirely
Overweight patients managing related health risks like type 2 diabetes, high blood pressure or heart disease may also benefit from their enhanced weight reduction
We have been using this technology in our Hertford clinic for over 5 years and continue to see the life-changing impact of these treatments
Cell viability was assessed 3 days after treatment with FOXO4-DRI at 0, 12.5, 25, 50, and 100 M, respectively, using the Cell Counting Kit-8 (CCK-8) Assay (Dojindo, Rockville, MD, United States)